Condition

TNBC clinical trials and research

• 7Clinical trials
• 10Countries

Newest TNBC clinical trials

All recruiting trials (7)

• Sac-TMT plus bevacizumab in TNBC with brain metastases

  This phase II, single-arm study tests whether Sac-TMT combined with bevacizumab can help people with triple-negative breast cancer and brain metastases.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT07623577

• Maintenance with QL1706 after chemo in high-risk triple-negative breast cancer

  This study tests whether adding QL1706 after standard chemotherapy can help people with high-risk triple-negative breast cancer stay cancer-free longer.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT07622836

• Ivonescimab with carboplatin and docetaxel for early triple-negative breast cancer

  This trial will test whether adding ivonescimab to neoadjuvant carboplatin and docetaxel helps people with early-stage triple-negative breast cancer.

  Recruiting at 3 sites Phase 2 Cedars-Sinai Medical Center · Los Angeles, California and 3 other locations · NCT07017673

• Combination therapy for advanced triple-negative breast cancer

  This study is testing a new combination of two drugs to see if it can help people with advanced triple-negative breast cancer live longer and feel better.

  Recruiting Peking University Cancer Hospital & Institute · Beijing · NCT06991790

• HS-10502 combination treatment for advanced solid tumors

  This study will test whether the oral drug HS-10502, given with other cancer medicines, is safe and can help people with advanced solid tumors such as recurrent ovarian cancer, HER2‑negative or triple‑negative breast cancer, and advanced prostate cancer.

  Recruiting Phase 1 Jiangsu Hansoh Pharmaceutical Co., Ltd. · Shanghai, Shanghai Municipality · NCT06769425

• Evaluating a new CAR T-cell therapy for solid tumors expressing EGFR

  This study is testing a new CAR T-cell therapy to see if it can safely help adults with certain solid tumors, like colorectal and lung cancer, that have specific markers.

  Recruiting at 10 sites Phase 1/2 A2 Biotherapeutics Inc. · Gilbert, Arizona and 9 other locations · NCT06682793

• Evaluating PC14586 for advanced solid tumors with a specific mutation

  This study is testing a new oral medication called PC14586 to see if it can help people with advanced solid tumors that have a specific mutation in the TP53 gene.

  Recruiting at 71 sites Phase 1/2 PMV Pharmaceuticals, Inc · Irvine, California and 75 other locations · NCT04585750

Related topics

Quick answers

How many TNBC clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in China (4 trials), United States (3 trials), Australia (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →